Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Heavy Ion Cancer Treatment Center (HICTC) is a specialized medical and research institution focused on the delivery of carbon-ion radiotherapy, a highly precise form of external beam radiation therapy. Utilizing the Heavy Ion Medical Machine (HIMM) developed by the Institute of Modern Physics at the Chinese Academy of Sciences, the center provides advanced treatment for various solid tumors that are often resistant to conventional X-ray therapy. The facility integrates clinical care with ongoing research into particle physics and radiobiology to optimize treatment protocols for complex cancers. HICTC represents a significant advancement in oncology within the region, offering a non-invasive alternative for patients with deep-seated or radioresistant malignancies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heavy Ion Center.